Third, this study did not include information on the biomarkers of Alzheimer’s disease (such as amyloid-β (Aβ42), total tau (T-tau) and phosphorylated tau (P-tau)) to confirm the diagnosis of Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.